BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 36688301)

  • 1. Validity of International Classification of Diseases (ICD)-10 Diagnosis Codes for Identification of Acute Heart Failure Hospitalization and Heart Failure with Reduced Versus Preserved Ejection Fraction in a National Medicare Sample.
    Bates BA; Akhabue E; Nahass MM; Mukherjee A; Hiltner E; Rock J; Wilton B; Mittal G; Visaria A; Rua M; Gandhi P; Dave CV; Setoguchi S
    Circ Cardiovasc Qual Outcomes; 2023 Feb; 16(2):e009078. PubMed ID: 36688301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of international classification of diseases, tenth revision, clinical modification diagnosis codes for heart failure subtypes.
    Pocobelli G; Ichikawa L; Yu O; Green BB; Meyers K; Gray R; Shea M; Chubak J
    Pharmacoepidemiol Drug Saf; 2022 Sep; 31(9):992-997. PubMed ID: 35670124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Electronic Health Record Diagnosis Codes for Ambulatory Heart Failure Encounters.
    Goyal P; Bose B; Creber RM; Krishnan U; Yang M; Brady J; Pathak J
    J Card Fail; 2020 Dec; 26(12):1060-1066. PubMed ID: 32755626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a heart failure with preserved ejection fraction cohort using electronic medical records.
    Patel YR; Robbins JM; Kurgansky KE; Imran T; Orkaby AR; McLean RR; Ho YL; Cho K; Michael Gaziano J; Djousse L; Gagnon DR; Joseph J
    BMC Cardiovasc Disord; 2018 Jun; 18(1):128. PubMed ID: 29954337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Preliminary Validation of a Medicare Claims-Based Model to Predict Left Ventricular Ejection Fraction Class in Patients With Heart Failure.
    Desai RJ; Lin KJ; Patorno E; Barberio J; Lee M; Levin R; Evers T; Wang SV; Schneeweiss S
    Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004700. PubMed ID: 30562067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary economic burden in a real-world heart failure population with Commercial and Medicare supplemental plans.
    Lam CSP; Wood R; Vaduganathan M; Bueno H; Chin A; Luporini Saraiva G; Sörstadius E; Tritton T; Thomas J; Qin L
    Clin Cardiol; 2021 May; 44(5):646-655. PubMed ID: 33704817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of claims-based definitions of left ventricular systolic dysfunction in Medicare patients.
    Li Q; Glynn RJ; Dreyer NA; Liu J; Mogun H; Setoguchi S
    Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):700-8. PubMed ID: 21608070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empagliflozin in Heart Failure With Predicted Preserved Versus Reduced Ejection Fraction: Data From the EMPA-REG OUTCOME Trial.
    Savarese G; Uijl A; Lund LH; Anker SD; Asselbergs F; Fitchett D; Inzucchi SE; Koudstaal S; Ofstad AP; Schrage B; Vedin O; Wanner C; Zannad F; Zwiener I; Butler J
    J Card Fail; 2021 Aug; 27(8):888-895. PubMed ID: 34364665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of claims-based computable phenotypes to identify heart failure patients with preserved ejection fraction.
    Cohen SS; Roger VL; Weston SA; Jiang R; Movva N; Yusuf AA; Chamberlain AM
    Pharmacol Res Perspect; 2020 Dec; 8(6):e00676. PubMed ID: 33124771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure.
    Mahesri M; Chin K; Kumar A; Barve A; Studer R; Lahoz R; Desai RJ
    PLoS One; 2021; 16(6):e0252903. PubMed ID: 34086825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
    Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
    ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes and Temporal Patterns of 30-Day Readmission Among Older Adults Hospitalized With Heart Failure With Preserved or Reduced Ejection Fraction.
    Goyal P; Loop M; Chen L; Brown TM; Durant RW; Safford MM; Levitan EB
    J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29686028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term Registry.
    Kapłon-Cieślicka A; Laroche C; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Maggioni AP; Hage C; Lara-Padrón A; Fucili A; Drożdż J; Seferovic P; Rosano GMC; Mebazaa A; McDonagh T; Lainscak M; Ruschitzka F; Lund LH;
    ESC Heart Fail; 2020 Oct; 7(5):2098-2112. PubMed ID: 32618139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ankle-brachial index and incident heart failure with reduced versus preserved ejection fraction: The Multi-Ethnic Study of Atherosclerosis.
    Prasada S; Shah SJ; Michos ED; Polak JF; Greenland P
    Vasc Med; 2019 Dec; 24(6):501-510. PubMed ID: 31480898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
    Vergaro G; Ghionzoli N; Innocenti L; Taddei C; Giannoni A; Valleggi A; Borrelli C; Senni M; Passino C; Emdin M
    J Am Heart Assoc; 2019 Oct; 8(20):e013441. PubMed ID: 31587602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world clinical diagnostics of heart failure patients with reduced or preserved ejection fraction.
    Huusko J; Purmonen T; Toppila I; Lassenius M; Ukkonen H
    ESC Heart Fail; 2020 Jun; 7(3):1039-1048. PubMed ID: 32187879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection Fraction.
    Tay WT; Teng TK; Simon O; Ouwerkerk W; Tromp J; Doughty RN; Richards AM; Hung CL; Qin Y; Aung T; Anand I; Lam CSP;
    J Am Heart Assoc; 2021 Nov; 10(22):e021414. PubMed ID: 34666509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes.
    Shah KS; Xu H; Matsouaka RA; Bhatt DL; Heidenreich PA; Hernandez AF; Devore AD; Yancy CW; Fonarow GC
    J Am Coll Cardiol; 2017 Nov; 70(20):2476-2486. PubMed ID: 29141781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.